These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

659 related items for PubMed ID: 31387637

  • 41.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 42. Activation of Valpha14(+) natural killer T cells by alpha-galactosylceramide results in development of Th1 response and local host resistance in mice infected with Cryptococcus neoformans.
    Kawakami K, Kinjo Y, Yara S, Koguchi Y, Uezu K, Nakayama T, Taniguchi M, Saito A.
    Infect Immun; 2001 Jan; 69(1):213-20. PubMed ID: 11119508
    [Abstract] [Full Text] [Related]

  • 43.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 44.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 45.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 46. Natural killer T cell activation overcomes immunosuppression to enhance clearance of postsurgical breast cancer metastasis in mice.
    Gebremeskel S, Clattenburg DR, Slauenwhite D, Lobert L, Johnston B.
    Oncoimmunology; 2015 Mar; 4(3):e995562. PubMed ID: 25949924
    [Abstract] [Full Text] [Related]

  • 47.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 48. Regulation of secondary antigen-specific CD8(+) T-cell responses by natural killer T cells.
    Hong C, Lee H, Park YK, Shin J, Jung S, Kim H, Hong S, Park SH.
    Cancer Res; 2009 May 15; 69(10):4301-8. PubMed ID: 19401453
    [Abstract] [Full Text] [Related]

  • 49.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 50. Potent immune-modulating and anticancer effects of NKT cell stimulatory glycolipids.
    Chang YJ, Huang JR, Tsai YC, Hung JT, Wu D, Fujio M, Wong CH, Yu AL.
    Proc Natl Acad Sci U S A; 2007 Jun 19; 104(25):10299-304. PubMed ID: 17566107
    [Abstract] [Full Text] [Related]

  • 51.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 52.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 53.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 54.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 55.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 56. A novel function of Valpha14+CD4+NKT cells: stimulation of IL-12 production by antigen-presenting cells in the innate immune system.
    Tomura M, Yu WG, Ahn HJ, Yamashita M, Yang YF, Ono S, Hamaoka T, Kawano T, Taniguchi M, Koezuka Y, Fujiwara H.
    J Immunol; 1999 Jul 01; 163(1):93-101. PubMed ID: 10384104
    [Abstract] [Full Text] [Related]

  • 57.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 58.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 59. Modulation of NKT cells and Th1/Th2 imbalance after alpha-GalCer treatment in progressive load-trained rats.
    Ru W, Peijie C.
    Int J Biol Sci; 2009 May 07; 5(4):338-43. PubMed ID: 19461936
    [Abstract] [Full Text] [Related]

  • 60. Activation of natural killer T cells by alpha-galactosylceramide treatment prevents the onset and recurrence of autoimmune Type 1 diabetes.
    Sharif S, Arreaza GA, Zucker P, Mi QS, Sondhi J, Naidenko OV, Kronenberg M, Koezuka Y, Delovitch TL, Gombert JM, Leite-De-Moraes M, Gouarin C, Zhu R, Hameg A, Nakayama T, Taniguchi M, Lepault F, Lehuen A, Bach JF, Herbelin A.
    Nat Med; 2001 Sep 07; 7(9):1057-62. PubMed ID: 11533711
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 33.